Avramescu RG,Hernandez G,Flores C .2024 .Rewiring the future: Drugs abused in adolescence may predispose to mental illness in adult life by altering dopamine axon growth. J. Neural. Transm., 131 : 461-467.
Kieffer Darcq E,BL Darcq E .2024 .Neuroscience and addiction research: Current advances and perspectives. J. Neural. Transm., 131(5) : 405-408.
Diepenbroek C,Rijnsburger M,van Irsen AAS,Eggels L,Kisner A,Foppen E,Unmehopa UA,Berland C,Dolleman S,Hardonk M,Cruciani-Guglielmacci C,Faust RP,Wenning R,Maya-Monteiro CM,Kalsbeek A,Aponte Y,Luquet S,Serlie MJM .2024 .Dopamine in the nucleus accumbens shell controls systemic glucose metabolism via the lateral hypothalamus and hepatic vagal innervation in rodents. Metabolism, 150 : 155696.
Duval F .2023 .Systematic review of the apomorphine challenge test in the assessment of dopaminergic activity in schizophrenia. Healthcare (Basel), 11(10) : 1487.
Estav PM,Albertson SE,Karkhanis AN,Jones SR .2024 .Co-targeting the kappa opioid receptor and dopamine transporter reduces motivation to selfadminister cocaine and partially reverses dopamine system dysregulation. Sci. Rep, 14 : 6509.
Ferron JC,Brunette MF,Aschbrenner KA,ElSayed MW,Pratt SI .2024 .Tobacco, alcohol, and drug use among young adults with serious mental illness. Community, 60(5) : 945-954.
Haleem DJ,Ikram H,Haleem MA H .2014 .Inhibition of apomorphine-induced conditioned place preference in rats co-injected with buspirone: Relationship with serotonin and dopamine in the striatum. Brain Res., 1586 : 73-82.
Hur KH,Lee Y,Donio AL,Kim SK,Lee BR,Seo JY,Kundu D,Kim KM,Kohut SJ,Lee SY,Jang CG .2024 .Transient receptor potential ankyrin 1 channel modulates the abuse-related mechanisms of methamphetamine through interaction with dopamine transporter. Br. J. Pharmacol., 181(16) : 2794-2809.
Ikram H,Masood R,Syed S,Haleem DJ S .2023 .Neuropharmacological studies on repurposed utilization of pioglitazone in learning and memory: A dose related study. Pak. J. Pharm. Sci., 36(4) : 1159-1167.
Ikram H,Tasneem S,Perveen S,Zakir R,Haleem DJ R .2021 .Neurochemical and behavioral effects of fluoxetine on midazolam induce dependence in an animal model of addiction. Pak. J. Pharm. Sci., 34(5) : 1749-1757.
Ikram H,Zakir R,Haleem DJ R,Jami ES,Hammerschlag AR,Sallis HM,Qiao Z,Andreassen OA,Magnus PM,Njølstad PR,Havdahl A,Pingault JB,Evans DM,Munafò MR,Ystrom E,Bartels M,Middeldorp C M .2023 .Do environmental effects indexed by parental genetic variation influence common psychiatric symptoms in childhood? Transl. Metab. Brain Dis, 13(1) : 94.
Jastrzębska J,Frankowska M,Smaga I,HubalewskaMazgaj M,Suder A,Pieniążek R,Filip M .2023 .Evaluation of the 5-HT2C receptor drugs RO 60-0175, WAY 161503 and mirtazepine in a preclinical model of comorbidity of depression and cocaine addiction. Pharmacol. Rep, 75 : 99-118.
Jastrzębska J,Frankowska M,Smaga I,HubalewskaMazgaj M,Suder A,Pieniążek R,Przegaliński E,Filip M .2023 .Evaluation of the 5-HT2C receptor drugs RO 60-0175, WAY 161503 and mirtazepine in a preclinical model of comorbidity of depression and cocaine addiction. Pharmacol. Rep, 75(1) : 99-118.
Jones BLH,Geier M,Neuhaus J,Coffin PO,Snyder HR,Soran CS,Knight KR,Suen LW .2024 .Withdrawal during outpatient low dose buprenorphine initiation in people who use fentanyl: A retrospective cohort study. Harm, 21(1) : 80.
Kassubek J,Factor SA,Balaguer E,Schwarz J,Chaudhuri RK,Isaacson SH,Wu S,Muhr CD,Kulisevsky T .2024 .Long-term safety, tolerability and efficacy of apomorphine sublingual film in patients with Parkinson's disease complicated by OFF episodes: a phase 3, open-label study. J. Neurol., 271 : 3554-3570.
Kassubek J,Jost WH,Schwarz J .2024 .Sublingual apomorphine in the treatment of Parkinson's disease. J. Neural. Transm., (Vienna), 131(10) : 1209-1216.
Kohtz AS,Zhao J,Aston-Jones G .2024 .Serotonin signaling in hippocampus during initial cocaine abstinence drives persistent drug seeking. J. Neurosci., 44(17) : e1505212024.
Koijam AS,Singh KD,Nameirakpam BS,Haobam R,Rajashekar Y .2024 .Drug addiction and treatment: An epigenetic perspective. , 170 : 115951.
Lauretani F,Giallauria F,Testa C,Zinni C,Lorenzi B,Zucchini I,Salvi M,Napoli R,Maggio MG .2024 .Dopamine pharmacodynamics: New insights. Int. J. Mol. Sci, 25(10) : 5293.
Monari PK,Hammond ER,Zhao X,Maksimoski AN,Petric R,Malone CL,Riters LV,Marler CA .2024 .Conditioned preferences: Gated by experience, context, and endocrine systems. Horm. Behav, 161 : 105529.
Negus SS .2024 .An economon model of drug addiction. Psychopharmacology (Berl), 241(3) : 417-425.
Porrino LJ,Smith HR,Beveridge TJR,Miller MD,Nader SH,Nader MA .2023 .Prolonged exposure to cocaine self-administration results in a continued progression of alterations in functional activity in a nonhuman primate model. Drug Alcohol Depend. Rep, 7(1) : 100148.
Tromp DPM,Fox AS,Riedel MK,Oler JA,Zhou X,Roseboom PH,Alexander AL,Kalin NH .2024 .Early life adversity in primates: Behavioral, endocrine, and neural effects. , 162 : 106953.
Wang X,Chen Y,Dong J,Ge J,Liu X,Liu J .2024 .Neurobiology of stress-induced nicotine relapse. Int. J. Mol. Sci, 25(3) : 1482.
Yuan S,Jiang SC,Zhang ZW,Li ZL,Hu J .2024 .Substance addiction rehabilitation drugs. Pharmaceuticals, 17(5) : 615.